Cent Eur J Public Health 2012, 20(4):248-251 | DOI: 10.21101/cejph.a3802

Tuberculosis Knowledge among Injecting Drug Users Visiting Syringe Exchange Program in Tallinn, Estonia

Kristi Rüütel1, R. David Parker2, Igor Sobolev3, Helle-Mai Loit1
1 National Institute for Health Development, Tallinn, Estonia
2 University of South Carolina, Columbia, SC, USA
3 NGO Estonian Network of People Living with HIV, Tallinn, Estonia

Background: The purpose of the current study was to describe tuberculosis (TB) knowledge, beliefs, and experience with TB services among injecting drug users.

Methods: Participants for this anonymous, cross-sectional study were recruited from a community based syringe exchange programme in Tallinn, Estonia. A structured questionnaire was completed and included information on socio-demographics, health history, drug use, and knowledge about TB and HIV.

Results: The study included 407 people (79% male, mean age 27.9 years, mean injection drug use 9.4 years). 32.9% of participants reported HIV infection and 1.7% lifetime history of TB. 26.4% participants (n=106) reported symptoms suggestive of TB. 93% of participants recognized correctly that TB is air-borne infection and 91% that HIV is a risk factor for TB. Only 40% of the participants knew that TB diagnostics and treatment in Estonia are free of charge for everybody and 58% reported they knew where to get health care services in case they suspected that they had TB. TB transmission and treatment adherence knowledge was better among those in contact with either health care or harm reduction services, e.g the community based syringe exchange programme.

Conclusion: Similar to HIV services, TB prevention and education should be integrated into harm reduction and drug treatment programmes to facilitate early diagnosis and treatment of TB among injecting drug users.

Keywords: injecting drug users, tuberculosis, HIV, harm reduction, syringe exchange

Received: June 6, 2012; Published: December 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Rüütel K, Parker RD, Sobolev I, Loit H. Tuberculosis Knowledge among Injecting Drug Users Visiting Syringe Exchange Program in Tallinn, Estonia. Cent Eur J Public Health. 2012;20(4):248-251. doi: 10.21101/cejph.a3802. PubMed PMID: 23441387.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Fears R, Kaufmann S, Ter Meulen V, ZumlaA; EASAC Working Group. Drug-resistant tuberculosis in the European Union: opportunities and challenges for control. Tuberculosis (Edinb). 2010 May;90(3):182-7. Go to original source... Go to PubMed...
    2. Perlman DC, Salomon N, Perkins MP, Yancovitz S, Paone D, Des Jarlais DC. Tuberculosis in drug users. Clin Infect Dis. 1995 Nov;21(5):1253-64. Go to original source... Go to PubMed...
    3. Hwang LY, Grimes CZ, Beasley RP, Graviss EA. Latent tuberculosis infections in hard-to reach drug using population - detection, prevention and control. Tuberculosis (Edinb). 2009 Dec;89 Suppl 1:S41-5. Go to original source... Go to PubMed...
    4. Platt L, Bobrova N, Rhodes T, UuskülaA, Parry JV, Rüütel K, et al. High HIV prevalence among injecting drug users in Estonia: implications for understanding the risk environment. AIDS. 2006 Oct 24;20(16):2120-3. Go to original source... Go to PubMed...
    5. Uusküla A, Rajaleid K, Talu A, Abel K, Rüütel K, Hay G. Estimating injection drug use prevalence using state wide administrative data sources: Estonia, 2004. Addict Res Theory. 2007;15(4):411-24. Go to original source...
    6. Rüütel K,TrummalA, Salekešin M, Pervilhac C. HIVepidemic in Estonia: analysis of strategic information. Copenhagen: WHO Regional Office for Europe; 2011.
    7. Des Jarlais DC, Perlis TE, Stimson GV, Poznyak V; WHO Phase II Drug Injection Collaborative Study Group. Using standardized methods for research on HIV and injecting drug use in developing/transitional countries: case study from the WHO Drug Injection Study Phase II. BMC Public Health. 2006 Mar 2;6:54. Go to original source... Go to PubMed...
    8. Salomon N, Perlman DC, Friedmann P, Perkins MP, Ziluck V, Des Jarlais DC, et al. Knowledge of tuberculosis among drug users. Relationship to return rates for tuberculosis screening at a syringe exchange. J Subst Abuse Treat. 1999 Apr;16(3):229-35. Go to original source...
    9. Wolfe H, Marmor M, Maslansky R, Nichols S, Simberkoff M, Des Jarlais D, et al. Tuberculosis knowledge among New York City injection drug users. Am J Public Health. 1995 Jul;85(7):985-8. Go to original source...
    10. Curth NK, Hansson LN, Storm F, Lazarus JV. Select barriers to harmreduction services for IDUs in eastern Europe. Cent Eur J Public Health. 2009 Dec;17(4):191-7. Go to original source...

    Return to the content